The Racing Medication and Testing Consortium board of directors has approved new national laboratory standards for testing, the implementation of a laboratory accreditation program and a new independent Equine Quality Assurance Program.
Time and money are two of the major roadblocks as the horse racing industry struggles to come to terms with medication, drug testing, and security, officials said March 4 during the joint annual meeting of Harness Tracks of America and the Thoroughbred Racing Associations.
Testing of post race samples for erythropoietin and darbepoietin antibodies will begin Nov. 1 in New York under an emergency rule approved Oct. 21 by the state's Racing and Wagering Board.
Most Popular Stories
- Chrome Facing Retirement With Poor BC Effort
- Midnight Lucky Out of F&M Sprint, Retired
- Dayatthespa Silenced All Doubters
- Ward Sends Talented Duo to Juvenile Turf
- WinStar Buys Half Interest in Daredevil
- Moreno in Sharp Breeders' Cup Classic Drill
- The Big Apple's Big Vote
- Fair Grounds Ordered to Restore Purse Funds
- NJ Sports Betting Put on Hold by Court Order
- Presque Isle Horsemen Payments Delayed